Cancer cells use a specific pathway to survive toxins and cell death
The NRF2 pathway helps cancer cells manage formaldehyde and resist ferroptosis.
Cancer cells balance the removal of metabolic by-products with redox homeostasis. The NRF2 pathway is often hyperactivated in cancer to manage these antioxidant defenses.
NRF2 promotes tolerance to formaldehyde by increasing the cystine transporter SLC7A11. This process is largely independent of glutathione (GSH).
Glutathione (GSH) is essential for suppressing ferroptotic cell death. Ferroptosis is a type of cell death.
In cells with active NRF2, formaldehyde reacts with cysteine to form a thiazolidine conjugate. Formaldehyde is a genotoxic one-carbon by-product.
Combining formaldehyde stress with SLC7A11 inhibition activates the integrated stress response. This suppresses global protein synthesis and reduces cell viability.
These findings show that NRF2 coordinates ferroptosis resistance and formaldehyde tolerance. This exposes a vulnerability by combining inhibition of cystine uptake and GSH synthesis.
Key facts
- NRF2 promotes formaldehyde tolerance by up-regulating the cystine transporter SLC7A11.
- Glutathione (GSH) is necessary for ferroptosis resistance.
- Formaldehyde reacts with cysteine to form a thiazolidine conjugate in NRF2-active cells.